Wilder's principle: pre-treatment value determines post-treatment response

Eur Heart J. 2015 Mar 1;36(9):576-9. doi: 10.1093/eurheartj/ehu467. Epub 2014 Dec 23.

Authors

Franz H Messerli¹, Sripal Bangalore², Roland E Schmieder³

Affiliations

¹ Division of Cardiology, Mt. Sinai, Icahn School of Medicine, New York, NY, USA messerli.f@gmail.com.
² Leon H. Charney Division of Cardiology, New York University School of Medicine, New York, USA.
³ Department of Nephrology and Hypertension, University Hospital of Erlangen, Erlangen, Germany.

PMID: 25540187
DOI: 10.1093/eurheartj/ehu467

No abstract available

Publication types

Review

MeSH terms

Antihypertensive Agents / therapeutic use*
Benzazepines / therapeutic use
Blood Pressure / drug effects*
Cardiovascular Agents / therapeutic use
Heart Rate / drug effects
Humans
Hypertension / drug therapy*
Hypertension / physiopathology
Ivabradine
Randomized Controlled Trials as Topic

Substances

Antihypertensive Agents
Benzazepines
Cardiovascular Agents
Ivabradine